COMMUNIQUÉS West-GlobeNewswire
-
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
30/03/2026 -
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
30/03/2026 -
Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations
30/03/2026 -
SEED Therapeutics Announces Poster Presentation at AACR Annual Meeting 2026
30/03/2026 -
Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate
30/03/2026 -
BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026
30/03/2026 -
Nordletics App, Reviewed by Nearly 5,000 Users, Expands Home Fitness Reach As Demand For Equipment-Free Wellness Solutions Grows
30/03/2026 -
Bloom Healthcare Launches In-Home Primary Care and Accountable Care Model in Missouri
30/03/2026 -
BiomX Adds Former Mossad Deputy to Advisory Board
30/03/2026 -
Tempest Reports Year End 2025 Financial Results and Provides Business Update
30/03/2026 -
Twig Fertility Brings a New Standard of Patient-Centric Fertility Care to Vancouver
30/03/2026 -
KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
30/03/2026 -
Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones
30/03/2026 -
Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
30/03/2026 -
SS Innovations Expands Global Opportunity with Regulatory Approval of the SSi Mantra Surgical Robotic System in Colombia, Oman, Sri Lanka and Kenya
30/03/2026 -
Transcenta Therapeutics Appoints Dr. Christopher Hwang as Head of Global Partnerships for HiCB Platform
30/03/2026 -
AP Biosciences and Tasly Finalize Amended Collaboration Agreement to Support Global Out-Licensing of AP505 (B1962)
30/03/2026 -
HealthEquity Appoints Sanford Health CEO Bill Gassen to Board of Directors
30/03/2026 -
Ultragenyx Announces FDA Clearance of Investigational New Drug (IND) Application for UX016, a Sialic Acid Prodrug for the Treatment of GNE Myopathy
30/03/2026
Pages